Mutation Research

• 

  Publication Venue For

  • Protein tyrosine phosphatase (PTP) inhibition enhances chromosomal stability after genotoxic stress: decreased chromosomal instability (CIN) at the expense of enhanced genomic instability (GIN)?.  735:51-55. 2012
  • Formaldehyde-induced mutagenesis in Saccharomyces cerevisiae: molecular properties and the roles of repair and bypass systems..  731:92-98. 2012
  • The functional IGFBP7 promoter -418G>A polymorphism and risk of head and neck cancer..  702:32-39. 2010
  • Association between reduced copy-number at T-cell receptor gamma (TCRgamma) and childhood allergic asthma: A possible role for somatic mosaicism..  690:89-94. 2010
  • Preliminary examination of polymorphisms of GSTM1, GSTT1, and GSTZ1 in relation to semen quality..  688:41-46. 2010
  • DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis..  663:77-83. 2009
  • Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: enhanced survival and mutagenesis..  660:40-46. 2009
  • Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes..  627:146-157. 2007
  • FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs..  610:21-30. 2006
  • Incision of trivalent chromium [Cr(III)]-induced DNA damage by Bacillus caldotenax UvrABC endonuclease..  610:85-92. 2006
  • Mutagenesis by exocyclic alkylamino purine adducts in Escherichia coli..  599:1-10. 2006
  • Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms..  533:3-36. 2003
  • ras oncogene mutations in diethylnitrosamine-induced hepatic tumors in medaka (Oryzias latipes), a teleost fish..  539:43-53. 2003
  • Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes..  509:165-174. 2002
  • DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer..  513:37-48. 2002
  • A new assay to quantify in vivo repair of G:T mispairs by base excision repair..  487:109-119. 2001
  • Human nucleotide excision repair protein XPA: NMR spectroscopic studies of an XPA fragment containing the ERCC1-binding region and the minimal DNA-binding domain (M59-F219)..  486:1-10. 2001
  • Risk assessment for developing gliomas: a comparison of two cytogenetic approaches..  490:35-44. 2001
  • Mismatch repair proteins and mitotic genome stability..  451:151-167. 2000
  • Needle-in-a-haystack detection and identification of base substitution mutations in human tissues..  406:79-100. 1999
  • The rate of mitochondrial mutagenesis is faster in mice than humans..  377:157-166. 1997
  • Genetic control of microsatellite stability..  383:61-70. 1997
  • The roles of telomeres and telomerase in cell life span..  366:45-63. 1996
  • Interlaboratory validation of a new assay for DNA-protein crosslinks..  369:13-21. 1996
  • Erratum to Mutation spectrum of 2-chloroethyl methanesulfonate in Drosophila melanogaster premeiotic germ cells' [Mutation Res. 331 (1995) 213-224]..  354:143-144. 1996
  • Mutation spectrum of 2-chloroethyl methanesulfonate in Drosophila melanogaster premeiotic germ cells..  331:213-224. 1995
  • Correlation of doxorubicin footprints with deletion endpoints in lacO of E. coli..  326:17-27. 1995
  • International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents..  309:109-142. 1994
  • In vitro and in vivo genotoxicity evaluation of hormonal drugs. II. Dexamethasone..  308:89-97. 1994
  • The influence of large deletions on the mutation frequency induced by tritiated water and X-radiation in male Drosophila melanogaster post-meiotic germ cells..  307:213-222. 1994
  • Excision repair reduces doxorubicin-induced genotoxicity..  294:215-222. 1993
  • Echinomycin, a bis-intercalating agent, induces C-->T mutations via cytosine deamination..  288:291-300. 1993
  • Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds..  300:179-193. 1993
  • Sequencing of double-stranded polymerase chain reaction products for mutation analysis..  288:181-185. 1993
  • DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells..  280:129-136. 1992
  • Repair of DNA damage induced by oxygen radicals in human non-proliferating and proliferating lymphocytes..  274:103-110. 1992
  • DNA adduct formation by 12 chemicals with populations potentially suitable for molecular epidemiological studies..  277:35-90. 1992
  • Clastogenicity of lead chromate particles in hamster and human cells..  278:69-79. 1992
  • Induction of micronuclei by X-radiation in human, mouse and rat peripheral blood lymphocytes..  253:193-198. 1991
  • Mutation of potassium permanganate- and hydrogen peroxide-treated plasmid pZ189 replicating in CV-1 monkey kidney cells..  261:123-130. 1991
  • The origin of O6-methylguanine-DNA methyltransferase in Chinese hamster ovary cells transfected with human DNA..  255:175-182. 1991
  • Actin cytoskeletal network in aging and cancer..  256:139-148. 1991
  • Stimulation of mutations suppressing the loss of replication control by small alcohols..  231:151-163. 1990
  • Analysis of ENU-induced mutations at the Adh locus in Drosophila melanogaster..  231:73-85. 1990
  • Comparison of dose-response relationships for ethyl methanesulfonate and 1-ethyl-1-nitrosourea in Drosophila melanogaster spermatozoa..  231:31-45. 1990
  • The importance of molecular dosimetry and analysis of mutations for estimation of genetic risk..  231:3-9. 1990
  • Mechanisms of DNA-mismatch correction..  236:253-267. 1990
  • Hydrolysis of N3-methyl-2'-deoxycytidine: model compound for reactivity of protonated cytosine residues in DNA..  215:131-138. 1989
  • Dosage-response relationships for methyl methanesulfonate in Drosophila melanogaster spermatozoa: DNA methylation per nucleotide vs. sex-linked recessive lethal frequency..  211:243-257. 1989
  • Improved EBV shuttle vectors..  220:125-132. 1989
  • Spectra of molecular changes induced in DNA of Drosophila spermatozoa by 1-ethyl-1-nitrosourea and X-rays..  199:255-268. 1988
  • Methyl-directed DNA mismatch repair in Escherichia coli..  198:37-43. 1988
  • Molecular analysis of Drosophila melanogaster AdhnLA405 confirms reliability of DNA-sequencing methodology..  207:53-56. 1988
  • A guide for performing germ cell mutagenesis assays using Drosophila melanogaster..  189:93-102. 1987
  • DNA base modification: ionized base pairs and mutagenesis..  177:201-218. 1987
  • Chromosome mutation tests for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program..  134:61-88. 1984
  • The sex-linked recessive lethal test for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program..  123:183-279. 1983
  • Modeling the Ames test..  85:13-27. 1981
  • Molecular dosimetry of the mutagen ethyl methanesulfonate in Drosophila melanogaster spermatozoa: linear relation of DNA alkylation per sperm cell (dose) to sex-linked recessive lethals..  49:27-44. 1978
  • Molecular dosimetry of chemical mutagens. Determination of molecular dose to the germ line..  38:311-316. 1976
  • Chromosome breakage in Drosophila melanogaster induced by a monofunctional alkylating agent (EMS)..  21:327-333. 1973
  • Comparison of a chemical assay with a tissue-mediated bio-assay for chemical mutagens..  16:215-221. 1972
  • Dosimetry of the chemical mutagen ethyl methanesulfonate in spermatozoan DNA from Drosophila melanogaster..  16:203-213. 1972
  • Transmutation of carbon-14 within DNA of Drosophila melanogaster spermatozoa..  16:195-201. 1972
  • Chemically induced mutations observed as mosaics in Drosophila melanogaster..  9:323-336. 1970